GPER1 and breast cancer: In particular, in human breast cancer cells, the activation of MAPK/ERK signalling by E2-GPER1 binding involves the heterotrimeric G-proteins βγ-subunits and the cytosolic kinase src activation, suggesting the contribution of the heparin-bound EGF cleavage [15].